Rhythm Pharmaceuticals, Inc. · NASDAQ:RYTM
Shulman Joseph sold 5,079 Rhythm Pharmaceuticals, Inc. shares (Form 4)
Traded Aug 13, 2026 · Filed Aug 17, 2026
On Aug 13, 2026, Shulman Joseph (Chief Technical Officer) sold 5,079 Rhythm Pharmaceuticals, Inc. shares at US$119.75 for US$608K under a trading plan, leaving 15,915 shares. Filed Aug 17, 2026 (Form 4).
- Sold
- 5,079 shares
- Price
- US$119.75
- Value
- US$608K
- Holding after
- 15,915 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Chief Technical Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Aug 13, 2026 | Common Stock | Option exercise | 2,024 | US$6.80 | 20,994 | Direct |
| Aug 13, 2026 | Common Stock | Sale | 5,079 | US$119.75 | 15,915 | Direct |
Source
Related
- Rhythm Pharmaceuticals, Inc.
- Shulman Joseph
- Rhythm Pharmaceuticals, Inc. shareholders
- Form 4 · Shulman Joseph · Nov 20, 2026
- Form 4 · Jean Christophe · Nov 18, 2026
- Schedule 13G · JPMorgan Chase & Co · Oct 13, 2026
- Form 4 · Meeker David P · Sep 14, 2026
- Form 4 · Smith Hunter C · Sep 1, 2026
- Form 4 · Garfield Alastair · Aug 17, 2026